Sign Out
Posology: Primary Vaccination: Subjects 9 months of age and over one 0.5 mL single injection of the reconstituted vaccine.
Booster: Paediatric population: Paediatric population (up to 18 years of age): If a long term protection* is required, one 0.5 mL dose of IMOJEV should be given as a booster dose after primary vaccination. The booster dose should be given preferably 12 months after primary vaccination and can be given up to 24 months after primary vaccination.
One 0.5 mL dose of Imojev can also be given as a booster vaccination in children who were previously given an inactivated Japanese encephalitis vaccine for primary vaccination, in accordance with the recommended timing for the booster of the inactivated Japanese encephalitis vaccine.
*Immunity is maintained at a high level at least 4 years after the booster dose when the vaccine used for primary vaccination is JE-CV (Imojev).
Adult population: The need for and timing of a possible booster dose have not yet been determined.
Method of administration: Once the freeze-dried vaccine has been completely reconstituted using the diluent provided (see Special precautions for disposal and other handling under Cautions for Usage), it is administered via the subcutaneous route.
In subjects 2 years of age and over, the recommended injection site is the deltoid region of the upper arm.
In subjects between 9 and 24 months of age, the recommended injection site is the anterolateral aspect of the thigh or the deltoid region.
Do not administer by intravascular injection.
IMOJEV must not be mixed with any other injectable vaccine(s) or medicinal product(s).
